Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prothena Corp (NQ: PRTA ) 23.61 -0.27 (-1.11%) Official Closing Price Updated: 4:15 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Prothena Corp < Previous 1 2 3 4 5 6 7 Next > Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win June 11, 2024 An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday. Via Investor's Business Daily Exposures Product Safety Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration May 28, 2024 From Prothena Corporation plc Via Business Wire PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024 May 08, 2024 PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Prothena Reports First Quarter 2024 Financial Results and Business Highlights May 08, 2024 From Prothena Corporation plc Via Business Wire Demystifying Prothena Corp: Insights From 8 Analyst Reviews March 13, 2024 Via Benzinga Decoding 6 Analyst Evaluations For Prothena Corp February 16, 2024 Via Benzinga Prothena Corp: Q4 Earnings Insights February 15, 2024 Via Benzinga Prothena to Report First Quarter 2024 Financial Results on May 8 May 01, 2024 From Prothena Corporation plc Via Business Wire Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma April 15, 2024 From Prothena Corporation plc Via Business Wire Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback March 28, 2024 The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting. Via Investor's Business Daily Exposures Product Safety Earnings Scheduled For February 15, 2024 February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. Via Benzinga Earnings Outlook For Prothena Corp February 14, 2024 Via Benzinga Navigating 5 Analyst Ratings For Prothena Corp January 25, 2024 Via Benzinga $100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today January 22, 2024 Via Benzinga Prothena to Participate in Upcoming Healthcare Conferences March 05, 2024 From Prothena Corporation plc Via Business Wire Prothena Appoints David Ford to Newly Created Chief People Officer Position March 04, 2024 From Prothena Corporation plc Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session February 29, 2024 Via Benzinga Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate February 21, 2024 From Prothena Corporation plc Via Business Wire Demystifying Prothena Corp: Insights From 5 Analyst Reviews January 09, 2024 Via Benzinga 4 Analysts Have This to Say About Prothena Corp December 18, 2023 Via Benzinga Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights February 15, 2024 From Prothena Corporation plc Via Business Wire Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 February 08, 2024 From Prothena Corporation plc Via Business Wire Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session January 09, 2024 U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market... Via Benzinga Topics Stocks Exposures US Equities Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 30, 2024 Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 08, 2024 Via Benzinga Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... Via Benzinga Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday January 08, 2024 U.S. stocks traded mixed, with the Dow Jones index falling around 80 points on Monday. Shares of The Boeing Company (NYSE: BA) fell during Friday’s session after an exit door blew out of a 737 aircraft... Via Benzinga Topics Stocks Exposures US Equities Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs January 08, 2024 From Prothena Corporation plc Via Business Wire Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others November 21, 2023 Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this Via Benzinga Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning November 17, 2023 Biotech companies are edging closer to finding the answers behind Alzheimer's disease. Via Investor's Business Daily < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.